Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Janus Henderson Short Duration Income ETF
VNLA
$3.34B
| $23.5M | 0.01% |
465,990
-500,744
| -52% | -$25.2M |
|
677
Halozyme
HALO
$9.88B
| $23.4M | 0.01% |
+889,303
| New | +$24.8M |
|
678
Peloton Interactive
PTON
$2.76B
| $23.1M | 0.01% |
232,905
+69,902
| +43% | +$5.14M |
|
679
Vanguard FTSE Europe ETF
VGK
$30.8B
| $23M | 0.01% |
438,931
+422,855
| +2,630% | +$22.6M |
|
680
Bio-Rad Laboratories Class A
BIO
$8.74B
| $22.8M | 0.01% |
44,302
+13,023
| +42% | +$6.6M |
|
681
ZTO Express
ZTO
$18.1B
| $22.8M | 0.01% |
762,130
-259,637
| -25% | -$8.86M |
|
682
Repay Holdings
RPAY
$328M
| $22.6M | 0.01% |
961,985
+47,255
| +5% | +$1.15M |
|
683
Independent Bank
INDB
$4.02B
| $22.6M | 0.01% |
431,379
-8,340
| -2% | -$519K |
|
684
FirstEnergy
FE
$28.2B
| $22.5M | 0.01% |
784,245
-266,694
| -25% | -$8.37M |
|
685
Amcor
AMCR
$20.9B
| $22.4M | 0.01% |
404,922
-120,700
| -23% | -$6.57M |
|
|
PXD
686
DELISTED
Pioneer Natural Resource Co.
PXD
| $22.4M | 0.01% |
260,146
-58,709
| -18% | -$5.78M |
|
687
Chubb
CB
$135B
| $22.3M | 0.01% |
192,298
-46,223
| -19% | -$5.81M |
|
688
Truist Financial
TFC
$63.5B
| $21.8M | 0.01% |
573,575
+175,460
| +44% | +$6.61M |
|
|
THR
689
DELISTED
Thermon Group Holdings
THR
| $21.7M | 0.01% |
1,933,722
+8,118
| +0.4% | +$107K |
|
690
Pinnacle West Capital
PNW
$12.3B
| $21.5M | 0.01% |
288,489
+157,841
| +121% | +$12.1M |
|
691
Skyworks Solutions
SWKS
$9.4B
| $21.5M | 0.01% |
147,738
-125,155
| -46% | -$17.4M |
|
692
Coca-Cola Femsa
KOF
$22.9B
| $21.5M | 0.01% |
+527,159
| New | +$22.1M |
|
693
Sun Life Financial
SLF
$45.9B
| $21.3M | 0.01% |
525,417
+32,313
| +7% | +$1.31M |
|
694
Brown & Brown
BRO
$23.7B
| $21.3M | 0.01% |
471,446
-31,253
| -6% | -$1.39M |
|
|
OSH
695
DELISTED
Oak Street Health, Inc.
OSH
| $21.3M | 0.01% |
+399,066
| New | +$17.9M |
|
696
LyondellBasell Industries
LYB
$19.5B
| $21.2M | 0.01% |
300,334
+230,212
| +328% | +$15.9M |
|
697
RPM International
RPM
$13.8B
| $21.1M | 0.01% |
254,307
-76,549
| -23% | -$6.25M |
|
698
Packaging Corp of America
PKG
$22.2B
| $21M | 0.01% |
192,876
-22,455
| -10% | -$2.3M |
|
699
Relay Therapeutics
RLAY
$4.24B
| $20.7M | 0.01% |
+486,611
| New | +$18.6M |
|
700
Arcturus Therapeutics
ARCT
$168M
| $20.7M | 0.01% |
483,078
+337,270
| +231% | +$16.7M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.